Well, I had a price forecast in my mind of 5c by the end of July but we have well and truly smashed that out of the park. And we still have the following to look forward to before the end of the month:
1. $2mill debt facility banked.
2. FDA approval
3. First Australian contract signed
It will be very interesting to see how this stock trades on these announcements as there are a lot more eyes on IME and the Medical Technology sector then a few months ago.
Also great to see Morgan’s and UBS hoovering up a lot of stock in June. It looks like Morgan’s have been towing their clients into IME since they released the research on the Radiological Informatics sector in mid-May.
There is still a lot of upside in IME, we are way undervalued on an ARR multiple compared to some of our peers. I can’t take credit for the below analysis but think it very worthwhile to share.
And then there is the long term blue sky:
1. Further growth coming out of South America – looking forward to seeing them penetrate the Brazilian market.
2. Entry into the western markets with Australia and the US to kick things off.
Good luck all bring on 10c… this should not be taken as investment advice.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.74M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16607 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 1000 | 1 |
View Market Depth
| Last trade - 16.21pm 17/09/2025 (20 minute delay) ? |
| IME (ASX) Chart |
Day chart unavailable